The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

Cookies

This site uses cookies for site interaction analysis with a purpose of service quality enhancing and uninterrupted site work. More details in Cookies Policy
Accept
14 October 2021

Paracetamol Darnitsa among consumers recommendations of Ukraine

14 October 2021

In 2020 the World Health Organization and world medics called paracetamol preparations one of the most effective remedies in lowering fever. This became particularly relevant during the Covid-2019 period. Last year, sales of paracetamol in Ukraine increased the records of previous years. The first of them is Paracetamol from the pharmaceutical company Darnitsa.

In 2021, Darnitsa decided not only to exceed last year's results, but also to organize the launch of the brand Paracetamol-Darnitsa in the mass media. The first wave of activity was held in March 2021, the second - in August 2021. According to Proxima Research, Paracetamol from Darnitsa, as before, is No.1 of sales in packages and money, actually exceeding the closest competitor by 3 times. As of the 3rd quarter of 2021, the share of sales of Paracetamol Darnitsa in the market of paracetamol monopreparations of Ukraine, in packages amounted to 71.1%, in money – 72.4%.

To ensure that Paracetamol-Darnitsa is a leader and stable brand for the Ukrainian consumer, Darnitsa also conducted a study among Ukrainian consumers aged 18-60 years, together with the Gradus company, based on the results of the 3rd quarter of 2021. 72% of consumers confirmed that they regularly bought Darnitsa Paracetamol, 70% are ready to recommend Paracetamol-Darnitsa to friends and relatives, about 40% of consumers associate Paracetamol only with Darnitsa company.

Share:
Specialized edition for medical institutions and doctors.